推薦產品
化驗
≥99%
形狀
rod
製造商／商標名
Goodfellow 980-419-89
電阻係數
126 μΩ-cm, 20°C
bp
3273 °C (lit.)
mp
1313 °C (lit.)
密度
7.886 g/mL at 25 °C (lit.)
SMILES 字串
[Gd]
InChI
1S/Gd
InChI 密鑰
UIWYJDYFSGRHKR-UHFFFAOYSA-N
尋找類似的產品？ 前往 產品比較指南
一般說明
For updated SDS information please visit www.goodfellow.com.
法律資訊
Product of Goodfellow
訊號詞
Warning
危險聲明
危險分類
Water-react 3
儲存類別代碼
4.3 - Hazardous materials which set free flammable gases upon contact with water
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。
Tevfik F Ismail et al.
Heart (British Cardiac Society), 100(23), 1851-1858 (2014-06-27)
Myocardial fibrosis identified by late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) in patients with hypertrophic cardiomyopathy (HCM) is associated with adverse cardiovascular events, but its value as an independent risk factor for sudden cardiac death (SCD) is unknown. We
Giovanni Antonini et al.
Pain, 155(8), 1464-1471 (2014-05-03)
Although classical trigeminal neuralgia (CTN) is frequently caused by neurovascular contact (NVC) at the trigeminal root entry zone (REZ), both anatomical and MRI studies have shown that NVC of the trigeminal nerve frequently occurs in individuals without CTN. To assess
J T Heverhagen et al.
RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 186(7), 661-669 (2014-01-31)
Nephrogenic systemic fibrosis (NSF) is a serious, sometimes fatal disease. Findings in recent years have shown that a causal association between gadolinium containing contrast media and NSF is most likely. Therefore, the regulatory authorities have issued guidelines on the use
John J Green et al.
JACC. Cardiovascular imaging, 5(4), 370-377 (2012-04-14)
The objective of this study was to perform a systematic review and meta-analysis of the predictive value of late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) for future cardiovascular events and death in hypertrophic cardiomyopathy (HCM). The utility of LGE
Anders Bruun Mathiasen et al.
European heart journal, 36(27), 1744-1753 (2015-05-01)
Regenerative treatment with mesenchymal stromal cells (MSCs) has been promising in patients with ischaemic heart failure but needs confirmation in larger randomized trials. We aimed to study effects of intra-myocardial autologous bone marrow-derived MSC treatment in patients with severe ischaemic
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務